Pediatric Psoriasis Comorbidities

Nicole W. Kittler, MD; Kelly M. Cordoro, MD


Skin Therapy Letter. 2020;25(5):1-6. 

In This Article


Approximately 40% of patients with psoriasis report onset in childhood or adolescence.[1,2] While the association between psoriasis and various extracutaneous comorbidities in adult patients is well established, questions remain about whether the same is true for pediatric patients. If the risk of comorbidities begins early in life, there is an opportunity for prevention, early detection and intervention for children suffering from or at risk of comorbid conditions. In 2017, the Pediatric Psoriasis Comorbidity Screening Initiative (CSI) published consensus-based screening recommendations for pediatric psoriasis patients,[3] which do not differ significantly from the routine age-appropriate screening guidelines for healthy children set forth by the American Academy of Pediatrics (AAP). Pediatricians and dermatologists caring for children and adolescents with psoriasis should understand the risk of various potential comorbidities so that they may appropriately screen and counsel patients and their parents.